Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,480 | 1,310 | 900 | 1,280 | 1,220 |
| TOTAL | $1,480 | $1,310 | $900 | $1,280 | $1,220 |
| Non-Current Assets | |||||
| PPE Net | 5,030 | N/A | N/A | 5,170 | 5,540 |
| Other Non-Current Assets | 470 | 870 | 990 | 1,220 | 1,450 |
| TOTAL | $5,500 | $870 | $990 | $6,390 | $6,990 |
| Total Assets | $6,980 | $2,180 | $1,890 | $7,670 | $8,210 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,310 | 2,820 | 2,410 | 2,070 | 2,580 |
| Accrued Expenses | 7,130 | 7,960 | 8,660 | 8,680 | 9,060 |
| Other current liabilities | 13,480 | 12,970 | 11,800 | 11,020 | 11,890 |
| TOTAL | $22,920 | $23,750 | $22,870 | $21,770 | $23,530 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 2,490 | 0 | 2,860 | 3,120 |
| TOTAL | $1,160 | $4,160 | $2,900 | $6,000 | $5,550 |
| Total Liabilities | $24,080 | $27,910 | $25,770 | $27,770 | $29,080 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Other shareholders' equity | 370 | 410 | 350 | 410 | 650 |
| TOTAL | $77,150 | $77,170 | $77,110 | $77,170 | $77,330 |
| Total Liabilities And Equity | $101,230 | $105,080 | $102,880 | $104,940 | $106,410 |